Exogenous photodermatoses is a type of skin reaction, which is caused by exposure to ultraviolet (UV) light from an outside source, known as exogenous UV exposure. The most common exogenous photodermatoses is polymorphous light eruption, which is an exaggerated inflammatory response that occurs after exposure to sunlight, but may also manifest after exposure to visible light or photosensitizing medications. This painful skin condition is characterized by an itchy, red rash that appears anywhere on the body, including the hands, arms, legs, and face. Ultraviolet light is divided into UVA, UVB and UVC sub-bands. UVA is the most prevalent form of UV light and has an energy level too low to cause direct damage to DNA, but is believed to initiate skin reactions. UVB on the other hand has an energy level high enough to directly cause DNA damage. Both forms of UV light can induce exogenous photodermatoses. The diagnosis of exogenous photodermatoses includes a thorough patient history to include recent medications, travel history, and whether the patient deliberately exposed their skin to UV light sources such as solariums or tanning beds. A patch test is also conducted and biopsies of the photodermatoses can be taken if required. Treatment of this disorder is purely preventative. It involves avoiding UV exposure on abnormally-sensitized skin. Sunscreen with a high protection factor should be worn during the summer to avoid direct sunburn. Protective clothing and hats can also help to significantly reduce the risk of developing an exogenous photodermatosis flare-up. In extreme cases, photochemotherapy using PUVA (psoralen-uvatum a) therapy may be recommended, but this employs the same type of UV light which causes the skin reaction. It is important to be aware of exogenous photodermatoses and prevention is key. If these preventative measures fail and the rash appears, topical medications such as glucocorticoids and other anti-inflammatory therapies may be employed. Seeking prompt medical attention is important to avoid exacerbations of this condition.
Title : Epitomic analysis revealed pemphigus autoantibodies against the ligand-binding pocket of M3 muscarinic acetylcholine receptor
Sergei A Grando, University of California Irvine, United States
Title : Dermatology and cosmetology through art and history of art
Dechelette Corinne, La Peau Autrement, France
Title : The new physiopathology of cellulite
Gustavo Hector Leibaschoff, World Society of Cosmetic Gynecology, United States
Title : A twelve week clinical study testing efficacy and safety of a cosmetic cream with novel actives for uneven skin tone, hyperpigmentation & photoaging
Nalini Kaul, Princeton Consumer Research, Canada
Title : Acne vulgaris and the most popular and new cosmetological treatments
Karolina Chilicka Hebel, University of Opole, Poland
Title : Bioregeneration in aesthetic and functional gynecology
Gustavo Hector Leibaschoff, World Society of Cosmetic Gynecology, United States
Title : Integrating personalized and precision medicine into dermatology clinical practice securing ITS potential to get skin diseases cured and to revolutionize dermatology
Sergey Suchkov, The Russian University for Medicine & The Russian Academy of Natural Sciences, Russian Federation
Title : Perspectives on healthy skin aging and pre-aging concepts
Georgios Stamatas, SGS France, France
Title : The management of FPHL- How it different from male AGA
Rachita Dhurat, LTMMC & LTMG Hospital, India
Title : Tackling stubborn wound by advanced polysaccharides-based biopolymer delivery system
Madhu Gupta, Delhi Pharmaceutical Science and Research University, India